TORONTO, Dec. 9, 2011 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. (“Transition”) (TSX:TTH) (Nasdaq:TTHI) today announces that Mr. Elie Farah, the Company’s President and Chief Financial Officer, has left the Company to pursue new challenges. During his time at Transition, Mr. Farah played an instrumental role in the Company listing on the NASDAQ, completing several equity financings, managing and executing multiple company acquisitions as well as licensing agreements with large pharmaceutical companies.
